神经系统疾病中的基于丹德里默的治疗方法:创新和临床前景
Karthikeya Lalitha Siddhartha Pallem1, Anjali Jain1, Anurag Aswal1
1Nanopolymeric Drug Delivery Lab, Department of Pharmacy, School of Chemical Sciences and Pharmacy, Central University of Rajasthan, Bandarsindri, Kishangarh, Ajmer, Rajasthan 305817, India..
Biochimica et biophysica acta. General subjects
|January 11, 2026
概括
登德里默通过克服血脑屏障 (BBB) 来治疗大脑疾病有望出现. 这些纳米载体可以向中枢神经系统 (CNS) 输送治疗药物,解决神经退行性疾病的有限治疗选择.
科学领域:
- 纳米技术纳米技术
- 神经科学是一个神经科学.
- 聚合物化学 聚合物化学
背景情况:
- 脑瘤和神经退行性疾病的发病率增加.
- 由于血脑屏障 (BBB) 的限制性,治疗选择有限.
- 在BBB范围内提供治疗药物的挑战,限制分子量 (<400Da) 和脂质溶解度.
研究的目的:
- 探索树突体的开发和应用,作为用于大脑药物输送的纳米载体.
- 审查树枝状物可以透BBB的机制.
- 总结一下最近在利用树枝状物用于中枢神经系统 (CNS) 治疗方面的进展.
主要方法:
- 关于树突聚合和应用的现有文献的全面审查.
- 对与BBB透相关的树突特性分析.
- 检查表明使用树枝状物向大脑输送治疗剂的研究.
主要成果:
- 登德里米生物具有独特的结构和功能性质,适合纳米载体的发展.
- 登德里默群体显示出在整个BBB地区提供高效和特定地点治疗药物的潜力.
- 在利用树枝状细胞在中枢神经系统中进行化疗和基因治疗方面取得了进展.
结论:
- 在治疗神经系统疾病时,登德里默是克服BBB局限性的有希望的策略.
- 进一步研究以树突分子为基础的药物递送系统可以提高中枢神经系统疾病的治疗效果.
- 登德里默为促进治疗药物的向大脑输送提供了一个多功能平台.
相关概念视频
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Microorganisms in Medicine and Therapeutics
925
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
925
Drug Delivery: Parenteral Route
1.5K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
1.5K


